136 related articles for article (PubMed ID: 15624740)
1. Etanercept and warts.
Adams DR; Zaenglein AL; Hershey MS
J Drugs Dermatol; 2004; 3(6):601. PubMed ID: 15624740
[No Abstract] [Full Text] [Related]
2. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
Lai JH
J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
[No Abstract] [Full Text] [Related]
3. Psoriasis after treatment of juvenile idiopathic arthritis with etanercept.
Peek R; Scott-Jupp R; Strike H; Clinch J; Ramanan AV
Ann Rheum Dis; 2006 Sep; 65(9):1259. PubMed ID: 16905590
[No Abstract] [Full Text] [Related]
4. Etanercept therapy in children with juvenile rheumatoid arthritis.
Hung JJ; Huang JL
J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346
[TBL] [Abstract][Full Text] [Related]
5. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
Bout-Tabaku S; Rivas-Chacon R; Restrepo R
J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
[No Abstract] [Full Text] [Related]
6. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
Carlson E; Rothfield N
Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
[No Abstract] [Full Text] [Related]
7. Hypersensitive joint reaction after etanercept treatment in a patient with juvenile rheumatoid arthritis.
Guo MM; Yang KD; Yu HR; Kuo HC
J Rheumatol; 2011 Mar; 38(3):577-9. PubMed ID: 21362794
[No Abstract] [Full Text] [Related]
8. Optic neuritis associated with etanercept therapy in two patients with extended oligoarticular juvenile idiopathic arthritis.
Tauber T; Daniel D; Barash J; Turetz J; Morad Y
Rheumatology (Oxford); 2005 Mar; 44(3):405. PubMed ID: 15637094
[No Abstract] [Full Text] [Related]
9. Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis.
Nádia EA; Carvalho JF; Bonfá E; Lotito AP; Silva CA
Isr Med Assoc J; 2009 Oct; 11(10):635-6. PubMed ID: 20077954
[No Abstract] [Full Text] [Related]
10. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
Gerloni V; Pontikaki I; Gattinara M; Fantini F
Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
[TBL] [Abstract][Full Text] [Related]
11. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Watson P; Simler N; Screaton N; Lillicrap M
Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
[No Abstract] [Full Text] [Related]
12. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Schneider R
J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
[TBL] [Abstract][Full Text] [Related]
13. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report.
Liang TC; Yang YH; Lin YT; Chiang BL
J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation syndrome and etanercept in children with systemic juvenile rheumatoid arthritis.
Sawar H; Espinoza LR; Gedalia A
J Rheumatol; 2004 Mar; 31(3):623; author reply 623-4. PubMed ID: 14994420
[No Abstract] [Full Text] [Related]
15. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.
Kimura Y; Pinho P; Walco G; Higgins G; Hummell D; Szer I; Henrickson M; Watcher S; Reiff A
J Rheumatol; 2005 May; 32(5):935-42. PubMed ID: 15868633
[TBL] [Abstract][Full Text] [Related]
16. The hemophagocytic syndrome/macrophage activation syndrome: a final common pathway of a cytokine storm.
Szyper-Kravitz M
Isr Med Assoc J; 2009 Oct; 11(10):633-4. PubMed ID: 20077953
[No Abstract] [Full Text] [Related]
17. Tuberculosis and treatment with infliximab.
Myers A; Clark J; Foster H
N Engl J Med; 2002 Feb; 346(8):623-6. PubMed ID: 11859881
[No Abstract] [Full Text] [Related]
18. Henoch-Schönlein purpura after etanercept therapy for psoriasis.
Lee A; Kasama R; Evangelisto A; Elfenbein B; Falasca G
J Clin Rheumatol; 2006 Oct; 12(5):249-51. PubMed ID: 17023811
[TBL] [Abstract][Full Text] [Related]
19. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.
Smith JA; Thompson DJ; Whitcup SM; Suhler E; Clarke G; Smith S; Robinson M; Kim J; Barron KS
Arthritis Rheum; 2005 Feb; 53(1):18-23. PubMed ID: 15696578
[TBL] [Abstract][Full Text] [Related]
20. Etanercept-induced encephalopathy in a 7-year-old child.
Ekici B; Aydın K; Cantez S; Ergül Y; Tatlı B
Pediatr Neurol; 2011 Oct; 45(4):271-3. PubMed ID: 21907894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]